Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025;25(6):399-410.
doi: 10.2174/0118715206341087241029064945.

Synthesis of Chromene-linked Bis-indole Derivatives as Selective Tumor-associated Carbonic Anhydrase IX Inhibitors

Priti Singh  1 , Sridhar Goud Nerella  1   2 , Baijayantimala Swain  1 , Andrea Angeli  3 , Samreen Kausar  4 , Qasim Ullah  4 , Claudiu T Supuran  3 , Mohammed Arifuddin  1   5
Affiliations

Synthesis of Chromene-linked Bis-indole Derivatives as Selective Tumor-associated Carbonic Anhydrase IX Inhibitors

Priti Singh et al. Anticancer Agents Med Chem. 2025.

Abstract

Background: Sulfonamide derivatives are well-reported hCA IX inhibitors; however, they inhibit all types of hCA without any selectivity, leading to severe adverse effects. Hence, developing a novel nonsulfonamide class of tumor-associated hCA IX inhibitors through non-classical inhibition may provide greater selectivity and better pharmacokinetics.

Objective: The objective of this study was to develop non-sulfonamide derivatives as potential human carbonic anhydrase (hCA) inhibitors and develop a new series of chromene-linked bis-indole derivatives.

Methods: We synthesized and characterized the chromene-linked bis-indole derivatives and further evaluated them against four hCA isoforms, i.e., hCA I, hCA II, hCA IX, and hCA XII, and determined the ADMET parameters by the In-silico method.

Results: Most of the compounds showed significantly greater affinity and selectivity towards the tumorassociated hCA IX over other hCA isoforms within the lower micromolar to submicromolar range. In particular, the bromo-substituted bis-indole derivative 6t showed an excellent inhibition of hCA IX isoform with an affinity (Ki) of 2.61 μM. In contrast, the cyano group substituted bis-indole derivative 6s and also displayed a strong inhibition of hCA IX isoform with an affinity (Ki) of 2.73 μM. Many other potential candidates, including 6g, 6i, 6k, 6m, 6o, 6p, and 6r, showed higher affinity at tumor-associated hCA IX with lower than 10 μM compared to other hCA isoforms.

Conclusion: Therefore, the chromene-linked bis-indole derivatives can serve as a novel non-sulfonamide class of tumor-associated hCA IX inhibitors.

Keywords: Chromene; anticancer agents.; bis-indole; hCA IX; human carbonic anhydrase; non-sulfonamide class.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Ganesh K.; Massagué J.; Targeting metastatic cancer. Nat Med 2021,27(1),34-44 - DOI - PubMed
    1. Sung H.; Ferlay J.; Siegel R.L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021,71(3),209-249 - DOI - PubMed
    1. Wang X.; Zhang H.; Chen X.; Drug resistance and combating drug resistance in cancer. Cancer Drug Resist 2019,2(2),141-160 - DOI - PubMed
    1. Anand U.; Dey A.; Chandel A.K.S.; Sanyal R.; Mishra A.; Pandey D.K.; De Falco V.; Upadhyay A.; Kandimalla R.; Chaudhary A.; Dhanjal J.K.; Dewanjee S.; Vallamkondu J.; Pérez de la Lastra J.M.; Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis 2023,10(4),1367-1401 - DOI - PubMed
    1. Nerella S.G.; Thacker P.S.; Arifuddin M.; Supuran C.T.; Tumor associated carbonic anhydrase inhibitors: Rational approaches, design strategies, structure activity relationship and mechanistic insights. Eur J Med Chem Reports 2024,10,100131 - DOI

MeSH terms

LinkOut - more resources